H.R.3012 - Right to Try Act of 2015114th Congress (2015-2016)
|Sponsor:||Rep. Salmon, Matt [R-AZ-5] (Introduced 07/09/2015)|
|Committees:||House - Energy and Commerce; Judiciary|
|Latest Action:||07/29/2015 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3012 — 114th Congress (2015-2016)All Information (Except Text)
Introduced in House (07/09/2015)
Right to Try Act of 2015
Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law.
Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.